Holy Hormones Journal: I am hoping to interview Dr. Segura on my radio show. She is in Spain and has been so outraged by what is happening not only to the injured but also the corruption that has taken place with science, the pharmaceutical companies and the governments. If anything these young women who lives have been so damaged are becoming the heroines in a travesty that has gone on for too long. We will forever question the safety and efficacy of a new drug that comes on the market. Until the next generation comes along… with no memory of what has happened in this part of history. This is why history is important… not to remember dates of wars… but to remember the context of the great issues of our time. And this my friends is one of the greatest. Never forget.
The Origins of the HPV Vaccine – A case of corruption in science
Dr. Gabriela Segura
November 5, 2015
The Human Papillomavirus (HPV) vaccine is possibly the most dangerous one on the market today. Supposedly designed to possibly prevent infections by certain types of human papillomavirus associated with the development of cervical cancer, genital warts, and other cancers, according to VAERS (Vaccine Adverse Event Reporting System), there were 41,236 adverse effects including 1,373 people disabled, 233 deaths, 705 life threatening cases and, 5,575 serious adverse effects up until September 2015.
Keep in mind that VAERS only reports cases from the United States. Some of the associated diseases after the HPV shot include Postural Orthostatic Tachycardia Syndrome, Complex Regional Pain Syndrome, Multiple Sclerosis, epilepsy, Lou Gehrig’s disease and several other serious conditions.
There are two companies manufacturing the HPV vaccine: “Gardasil and Gardasil 9” by Merck & Company and “Cervarix” by GlaxoSmithKline. The following settlement regarding GlaxoSmithKline should leave no doubts about their reputation:
“Largest Health Care Fraud Settlement in U.S. History
Monday, July 2, 2012
Despite these facts, the vaccine is still on the market and regarded as “safe” in most countries. An exception was given by Japan which withdrew its recommendation in 2013 and has not reversed that decision because of concerns from the public about adverse events. Others are taking notice as well. According to Medscape Medical News, the European Medicines Agency announced in July 2015 that it was conducting a safety review of HPV vaccines, which was requested by Denmark, where reports of adverse events after HPV vaccination have been widely reported in the media.
Denmark’s public awareness stems from this documentary which was aired on TV2, a national channel:
Some people might be familiar with Santa Cruz (Guanacaste) in Costa Rica. In fact, Costa Rica holds one of the highest density of clinical trials per population in the whole world. In other words, its population are good guinea pigs. Much of what is known about the HPV vaccine comes from there. The research began in 1985 in Guanacaste which, by then, was the country’s poorest region.
The following article published in March 2015 reveals some disturbing facts regarding the HPV vaccine tested in Costa Rica:
Antonio Ugalde, Professor Emeritus at the University of Texas at Austin.
Núria Homedes, Doctor in Public Health and director of global health at the University of Texas-Houston School of Public Health.
This article explains the difficulties innovative pharmaceutical firms have in repaying shareholders with attractive dividends. The problem is the result of the expiration of the patents of blockbuster drugs and the difficulties that the firms have in bringing new blockbuster drugs to the market. One of the solutions companies have found has been to accelerate the implementation of clinical trials in order to expedite the commercialization of new drugs. Doing so increases the period in which they can sell drugs at monopoly prices. We therefore discuss how innovative pharmaceutical firms shorten the implementation time of clinical trials in Latin America and the consequences such actions have on the quality of the collected data, the protection of human rights of the subjects of experimentation, and compliance with the ethical principles approved in international declarations.”